New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 18, 2021 - Zydus Pharmaceuticals launched an AP-rated generic version of Novartis’ Arranon (nelarabine) injection.
Download PDF
Return to publications
